Skip to main content
Article thumbnail
Location of Repository

Is Brain Banking of Psychiatric Cases Valuable for Neurobiological Research?

By Andrea Schmitt, Eleni Parlapani, Manfred Bauer, Helmut Heinsen and Peter Falkai

Abstract

It is widely accepted that neurobiological abnormalities underlie the symptoms of psychiatric disorders such as schizophrenia and unipolar or bipolar affective disorders. New molecular methods, computer-assisted quantification techniques and neurobiological investigation methods that can be applied to the human brain are all used in post-mortem investigations of psychiatric disorders. The following article describes modern quantitative methods and recent post-mortem findings in schizophrenia and affective disorders. Using our brain bank as an example, necessary considerations of modern brain banking are addressed such as ethical considerations, clinical work-up, preparation techniques and the organization of a brain bank, the value of modern brain banking for investigations of psychiatric disorders is summarized

Topics: Review Article
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier: oai:pubmedcentral.nih.gov:2664212
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. [Neuropathological diagnosis of neurodegenerative and dementia diseases].
    2. (1984). A neurohistological correlate of schizophrenia. Biol Psychiatry.
    3. A novel strategy for quantitative proteomics using isotope-coded protein labels.
    4. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry.
    5. (1997). A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex.
    6. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.
    7. (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry.
    8. A review of MRI findings in schizophrenia. Schizophr Res.
    9. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res.
    10. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry.
    11. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex.
    12. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52:805-18; discussion 819-20.
    13. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.
    14. Altered expression of mitochondriarelated genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet.
    15. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry.
    16. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.
    17. (1987). An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry.
    18. (1993). An empirical comparison of diagnoses and reliabilities
    19. (1997). and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia.
    20. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder.
    21. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    22. Autism brain tissue banking.
    23. Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study. Prog Neuropsychopharmacol Biol Psychiatry.
    24. Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia. Schizophr Res.
    25. (1985). Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry.
    26. Basic pathophysiological mechanisms in depression: what are they and how might they affect the course of the illness?
    27. Brain bank of the Brazilian aging brain study group - a milestone reached and more than 1,600 collected brains. Cell and tissue banking.
    28. (1992). Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials. Prog Brain Res.
    29. (1995). Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.
    30. (1999). Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry.
    31. (1986). Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci.
    32. Cerebral ventricular size and cognitive impairment in chronic schizophrenia.
    33. (2007). Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology.
    34. Contributions to the pathological anatomy of the cerebral cortex and the anatomical basis of some psychoses.
    35. Death of the teaching autopsy.
    36. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects.
    37. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry.
    38. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry.
    39. (1999). Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry.
    40. Dementia praecox.
    41. Design-based stereology in neuroscience.
    42. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.
    43. (1995). Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res.
    44. (2001). DNA microarrays in neuropsychopharmacology. Trends Pharmacol Sci.
    45. Dysregulation of the fibroblast growth factor system in major depression.
    46. educational, and epidemiological value of autopsy.
    47. Emerging technologies for large-scale screening of human tissues and fluids in the study of severe psychiatric disease.
    48. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry.
    49. Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia.
    50. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar disorders.
    51. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.
    52. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.
    53. Genes for schizophrenia? Recent findings and their pathophysiological implications.
    54. Genome-wide expression analysis reveals dysregulation of myelinationrelated genes in chronic schizophrenia.
    55. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia.
    56. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry.
    57. (1900). Grundriss der Psychiatrie in klinischen Vorlesungen.
    58. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry.
    59. (1991). Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry.
    60. Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment.
    61. Hippocampal volume and depression: a meta-analysis of MRI studies.
    62. (1921). Histologie und Histopathologie. Arbeiten über die Grosshirnrinde mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskrankheiten.
    63. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.
    64. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.
    65. (2006). Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol Dis.
    66. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.
    67. (2006). Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry.
    68. (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry.
    69. Intact hippocampal gray matter in schizophrenia as revealed by automatized image analysis postmortem. Anat Embryol (Berl).
    70. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium.
    71. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus.
    72. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res.
    73. (1988). Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. Biol Psychiatry.
    74. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry.
    75. Meta-analysis of regional brain volumes in schizophrenia.
    76. Microarray analysis of postmortem temporal cortex from patients with schizophrenia.
    77. Mitochondrial dysfunction in bipolar disorder: from 31P-magnetic resonance spectroscopic findings to their molecular mechanisms. International review of neurobiology.
    78. Mitochondrial dysfunction in bipolar disorder. Bipolar disorders.
    79. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry.
    80. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res.
    81. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry.
    82. (2004). Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry.
    83. (1998). Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res.
    84. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis.
    85. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry.
    86. Neurobiology of depression.
    87. Neuropathologic correlates of late-onset major depression.
    88. Neuropathological stageing of Alzheimer-related changes.
    89. (1991). Neuropathologically confirmed Alzheimer‘s disease: clinical diagnoses in 394 cases.
    90. No evidence for astrogliosis in brains of schizophrenic patients. A postmortem study.
    91. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
    92. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry.
    93. (2007). Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry.
    94. Phases of A beta-deposition in the human brain and its relevance for the development of AD.
    95. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia.
    96. Prenatal developmental disturbances in the limbic allocortex in schizophrenics.
    97. Progressive supranuclear palsy: clinico-pathological and biochemical studies.
    98. (1990). Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry.
    99. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.
    100. Proteomic profiling and neurodegeneration in Alzheimer’s disease. Neurochem Res.
    101. Proteomics: new perspectives, new biomedical opportunities.
    102. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease.
    103. Pyruvate oxidase in brain:
    104. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach.
    105. Reconsidering the classification of schizophrenia and manic depressive illness--a critical analysis and new conceptual model.
    106. (1998). Recovery of the rodent brain after cardiac arrest: a functional MRI study. Magn Reson Med.
    107. (2006). Reduced hippocampal volume in drug-free depressed patients. Surg Radiol Anat.
    108. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex.
    109. Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis.
    110. Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca‘s area 44 and area
    111. RNA amplification in brain tissues. Neurochem Res.
    112. (2008). Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei. Schizophr Res.
    113. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10:40-68; image 45.
    114. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics.
    115. Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder. Journal of neuropathology and experimental neurology.
    116. (1995). Serial analysis of gene expression.
    117. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity.
    118. Single-cell molecular biology.
    119. (1997). Subtractive cloning: past, present, and future. Annu Rev Biochem.
    120. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness.
    121. synaptic plasticity, and schizophrenia. International review of neurobiology.
    122. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet.
    123. Temporal lobe asymmetries as the key to the etiology of schizophrenia.
    124. The dementias.
    125. The evolution and pathology of frontotemporal dementia.
    126. The genetics of bipolar affective disorder. Current opinion in psychiatry.
    127. The Netherlands brain bank--a clinico-pathological link in aging and dementia research.
    128. The significance of the term hippocampus.
    129. (2000). The stanley foundation brain collection and neuropathology consortium. Schizophr Res.
    130. The temporal lobe in schizophrenia from uni- and multiply affected families.
    131. (2002). The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study. Psychiatry Res.
    132. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry.
    133. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biological psychiatry.
    134. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.
    135. (1925). Vergleichende Lokalisationslehre der Großhirnrinde.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.